Arcadia Biosciences, Inc.
RKDACIK 0001469443 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0009
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Arcadia Biosciences, Inc.
| Name | Roles | Filings |
|---|---|---|
| Schaefer Thomas J. | Officer | 9 |
| Kawakami Mark | Officer | 4 |
| Bolles Albert D. | Director | 3 |
| Carosella Deborah D | Director | 3 |
| Comcowich Kevin | Director | 3 |
Showing 1-5 of 11
Page 1 of 3Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Arcadia Biosciences, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Schaefer Thomas J. | 5 | 20% | -13.2% | -22.6% | +43.7% | -42.6% |
All filings
37 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|